Automating Pulmonology Inpatient Admission Prior Auth

The Unique Demands of Pulmonology Inpatient Prior Authorization

Inpatient prior authorization for pulmonology services encompasses a range of acute and chronic conditions, from severe asthma exacerbations requiring biologic management to critical care for COPD. Unlike scheduled outpatient procedures, inpatient admissions are often unscheduled and require immediate action to secure authorization within tight payer-mandated windows. This necessitates a system that can respond in real-time to admission events and manage both initial notification and ongoing concurrent reviews.

Key Prior Authorization Triggers in Pulmonology Inpatient Care

• Initiation or continuation of asthma biologics (e.g., Dupixent, Nucala, Fasenra, Tezspire) during an acute exacerbation.
• Emergency or urgent admissions for severe COPD exacerbations or acute respiratory failure.
• Utilization of home oxygen or BiPAP/CPAP equipment following discharge from an inpatient stay.
• Evaluation for lung transplant or management of post-transplant immunosuppression.
• Admission for pulmonary function testing that requires inpatient monitoring.
• Initiation of IPF antifibrotics (e.g., Esbriet, Ofev) in specific clinical scenarios.

Klivira's Automated Inpatient Admission Workflow

Klivira streamlines the entire pulmonology inpatient admission prior authorization process, leveraging real-time data integration to minimize manual effort and reduce delays. Our platform ingests HL7 v2 ADT events directly from your EMR, automatically identifying the responsible payer and initiating the required admission notification within critical timeframes. This ensures compliance with payer requirements and facilitates timely care delivery.

Seamless Integration Points for Efficient Authorization

• **EMR Integration:** Real-time ingestion of HL7 v2 ADT events for immediate admission notification.
• **Clinical Data Exchange:** FHIR-based updates for daily concurrent reviews and continued stay justification.
• **Payer Connectivity:** Automated submission via X12 278, payer portals, or Da Vinci PAS where supported.
• **Policy Libraries:** Integration with payer-specific guidelines and clinical criteria (e.g., MCG, InterQual).
• **Documentation Automation:** Extraction of key clinical data like eosinophil counts for asthma biologic approvals.

Concurrent Review and Observation Status Determination

Beyond initial admission, Klivira automates the critical process of concurrent stay reviews, pushing periodic clinical updates to payers to justify continued inpatient care based on criteria like MCG or InterQual. Our system also assists in the complex determination of observation versus inpatient status at admission, surfacing appropriate level-of-care recommendations to avoid payer denials and ensure correct billing for pulmonology patients. This is particularly relevant for conditions like acute bronchitis or pneumonia where status can be ambiguous.

Evidence-Based Authorization for Respiratory Care

Klivira incorporates clinical guideline awareness into its authorization logic, referencing standards such as ATS, GOLD for COPD, and GINA for asthma. For high-cost asthma biologics, the platform automates the documentation of essential requirements like eosinophil counts and prior step-therapy trials, which are common denial reasons without proper substantiation. This ensures that submitted authorizations align with clinical best practices and payer policies.